Larimar Therapeutics, Inc. (LRMR)
NASDAQ·Healthcare·Biotechnology
$3.66
-4.44%
Mkt Cap $415.53M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (7 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+228.3%
Consensus $12.00 vs current $3.66
NASDAQ·Healthcare·Biotechnology
$3.66
-4.44%
Mkt Cap $415.53M
Buy
6
Hold
0
Sell
0
Price Target (7 analysts)
$12.00
Range $12.00 – $12.00
+228.3%
Consensus $12.00 vs current $3.66